Management of Acute Gout Flare with Indomethacin

Recommended Treatment Course

• The American College of Physicians recommends indomethacin 50 mg three times daily for days 1-2, followed by a reduction to 25 mg three times daily for days 3-5, with a total treatment duration of 5-7 days or until complete symptom resolution 1, 2

Evidence-Based Dosing Strategy

• Treatment should be initiated within 24 hours of symptom onset for optimal efficacy, with early initiation associated with faster resolution and better outcomes 2
• The usual treatment course is 5-7 days, with a balance between efficacy and safety, as continuing high-dose indomethacin beyond 2-3 days increases the risk of adverse effects without additional benefit 2

Important Safety Caveats

• Indomethacin carries significant gastrointestinal toxicity, with adverse events reported in 55-63% of patients, substantially higher than corticosteroid alternatives, and should be used with caution in patients with severe renal impairment, history of gastrointestinal bleeding or ulceration, heart failure, or cirrhosis 2

Alternative Considerations

• The American College of Rheumatology notes that moderate-quality evidence shows no difference in efficacy between indomethacin and other NSAIDs, such as naproxen or ibuprofen, and that corticosteroids provide equivalent efficacy with fewer adverse effects, particularly gastrointestinal complications 1, 3

Long-Term Management Note

• The European League Against Rheumatism recommends that ongoing urate-lowering therapy should not be interrupted during the acute attack, and that appropriate prophylaxis, such as low-dose colchicine or NSAIDs for at least 8 weeks, should be ensured when initiating or adjusting urate-lowering therapy 2, 3, 4